260 related articles for article (PubMed ID: 11420691)
1. FGF-8b increases angiogenic capacity and tumor growth of androgen-regulated S115 breast cancer cells.
Mattila MM; Ruohola JK; Valve EM; Tasanen MJ; Seppänen JA; Härkönen PL
Oncogene; 2001 May; 20(22):2791-804. PubMed ID: 11420691
[TBL] [Abstract][Full Text] [Related]
2. Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells.
Ruohola JK; Viitanen TP; Valve EM; Seppänen JA; Loponen NT; Keskitalo JJ; Lakkakorpi PT; Härkönen PL
Cancer Res; 2001 May; 61(10):4229-37. PubMed ID: 11358849
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor 8 increases breast cancer cell growth by promoting cell cycle progression and by protecting against cell death.
Nilsson EM; Brokken LJ; Härkönen PL
Exp Cell Res; 2010 Mar; 316(5):800-12. PubMed ID: 19962979
[TBL] [Abstract][Full Text] [Related]
4. Androgen and fibroblast growth factor (FGF) regulation of FGF receptors in S115 mouse mammary tumor cells.
Ruohola JK; Valve EM; Vainikka S; Alitalo K; Härkönen PL
Endocrinology; 1995 May; 136(5):2179-88. PubMed ID: 7536664
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis by fibroblast growth factor 4 is mediated through an autocrine up-regulation of vascular endothelial growth factor expression.
Deroanne CF; Hajitou A; Calberg-Bacq CM; Nusgens BV; Lapière CM
Cancer Res; 1997 Dec; 57(24):5590-7. PubMed ID: 9407972
[TBL] [Abstract][Full Text] [Related]
6. Androgen and fibroblast growth factor 8 (FGF8) downregulation of thrombospondin 1 (TSP1) in mouse breast cancer cells.
Mattila MM; Tarkkonen KM; Seppänen JA; Ruohola JK; Valve EM; Härkönen PL
Mol Cell Endocrinol; 2006 Jul; 253(1-2):36-43. PubMed ID: 16723184
[TBL] [Abstract][Full Text] [Related]
7. Activation of Fgf8 in S115 mouse mammary tumor cells is associated with genomic integration of mouse mammary tumor virus.
Valve EM; Tasanen MJ; Ruohola JK; Härkönen PL
Biochem Biophys Res Commun; 1998 Sep; 250(3):805-8. PubMed ID: 9784427
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis.
Hajitou A; Sounni NE; Devy L; Grignet-Debrus C; Lewalle JM; Li H; Deroanne CF; Lu H; Colige A; Nusgens BV; Frankenne F; Maron A; Yeh P; Perricaudet M; Chang Y; Soria C; Calberg-Bacq CM; Foidart JM; Noël A
Cancer Res; 2001 Apr; 61(8):3450-7. PubMed ID: 11309307
[TBL] [Abstract][Full Text] [Related]
9. Transforming activity of a newly cloned androgen-induced growth factor.
Kouhara H; Koga M; Kasayama S; Tanaka A; Kishimoto T; Sato B
Oncogene; 1994 Feb; 9(2):455-62. PubMed ID: 8290257
[TBL] [Abstract][Full Text] [Related]
10. FGF-8b induces growth and rich vascularization in an orthotopic PC-3 model of prostate cancer.
Valta MP; Tuomela J; Vuorikoski H; Loponen N; Väänänen RM; Pettersson K; Väänänen HK; Härkönen PL
J Cell Biochem; 2009 Jul; 107(4):769-84. PubMed ID: 19415685
[TBL] [Abstract][Full Text] [Related]
11. High frequency of fibroblast growth factor (FGF) 8 expression in clinical prostate cancers and breast tissues, immunohistochemically demonstrated by a newly established neutralizing monoclonal antibody against FGF 8.
Tanaka A; Furuya A; Yamasaki M; Hanai N; Kuriki K; Kamiakito T; Kobayashi Y; Yoshida H; Koike M; Fukayama M
Cancer Res; 1998 May; 58(10):2053-6. PubMed ID: 9605740
[TBL] [Abstract][Full Text] [Related]
12. Autocrine growth stimulation by secreted Kaposi fibroblast growth factor but not by endogenous basic fibroblast growth factor.
Wellstein A; Lupu R; Zugmaier G; Flamm SL; Cheville AL; Delli Bovi P; Basilico C; Lippman ME; Kern FG
Cell Growth Differ; 1990 Feb; 1(2):63-71. PubMed ID: 1964794
[TBL] [Abstract][Full Text] [Related]
13. FGF-8 isoforms differ in NIH3T3 cell transforming potential.
MacArthur CA; Lawshé A; Shankar DB; Heikinheimo M; Shackleford GM
Cell Growth Differ; 1995 Jul; 6(7):817-25. PubMed ID: 7547503
[TBL] [Abstract][Full Text] [Related]
14. [Molecular mechanism of androgen-dependent transformation--analysis using serum-free culture system].
Koga M; Kouhara H; Sato B
Hum Cell; 1993 Sep; 6(3):176-81. PubMed ID: 8297813
[TBL] [Abstract][Full Text] [Related]
15. Roles of transforming growth factor beta in inhibition of androgen-induced growth of Shionogi carcinoma cells in serum-free medium.
Yamanishi H; Nonomura N; Tanaka A; Yasui T; Nishizawa Y; Matsumoto K; Sato B
Cancer Res; 1990 Oct; 50(19):6179-83. PubMed ID: 2169337
[TBL] [Abstract][Full Text] [Related]
16. Suramin interrupts androgen-inducible autocrine loop involving heparin binding growth factor in mouse mammary cancer (Shionogi carcinoma 115) cells.
Kasayama S; Saito H; Kouhara H; Sumitani S; Sato B
J Cell Physiol; 1993 Feb; 154(2):254-61. PubMed ID: 7678839
[TBL] [Abstract][Full Text] [Related]
17. MCF-7 breast carcinoma cells overexpressing FGF-1 form vascularized, metastatic tumors in ovariectomized or tamoxifen-treated nude mice.
Zhang L; Kharbanda S; Chen D; Bullocks J; Miller DL; Ding IY; Hanfelt J; McLeskey SW; Kern FG
Oncogene; 1997 Oct; 15(17):2093-108. PubMed ID: 9366526
[TBL] [Abstract][Full Text] [Related]
18. Unsaturated fatty acids are required for continuous proliferation of transformed androgen-dependent cells by fibroblast growth factor family proteins.
Kasayama S; Koga M; Kouhara H; Sumitani S; Wada K; Kishimoto T; Sato B
Cancer Res; 1994 Dec; 54(24):6441-5. PubMed ID: 7987840
[TBL] [Abstract][Full Text] [Related]
19. Basic fibroblast growth factor confers a less malignant phenotype in MDA-MB-231 human breast cancer cells.
Korah RM; Sysounthone V; Golowa Y; Wieder R
Cancer Res; 2000 Feb; 60(3):733-40. PubMed ID: 10676661
[TBL] [Abstract][Full Text] [Related]
20. Testosterone-induced growth of S115 mouse mammary tumor cells is dependent on heparan sulfate.
Borgenström M; Tienhaara A; Spillmann D; Salmivirta M; Jalkanen M
Exp Cell Res; 2001 Apr; 264(2):307-14. PubMed ID: 11262187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]